Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2006 1
2007 1
2008 2
2009 5
2010 2
2011 8
2012 7
2013 4
2014 8
2015 9
2016 5
2017 6
2018 7
2019 4
2020 1
2021 3
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
High-Dose Methotrexate as CNS Prophylaxis in High-Risk Aggressive B-Cell Lymphoma.
Lewis KL, Jakobsen LH, Villa D, Smedby KE, Savage KJ, Eyre TA, Cwynarski K, Bishton MJ, Fox CP, Hawkes EA, Maurer MJ, El-Galaly TC, Cheah CY; International CNS Prophylaxis Study Group. Lewis KL, et al. J Clin Oncol. 2023 Dec 10;41(35):5376-5387. doi: 10.1200/JCO.23.00365. Epub 2023 Oct 5. J Clin Oncol. 2023. PMID: 37797284
Obinutuzumab for B-cell malignancies.
Owen CJ, Stewart DA. Owen CJ, et al. Among authors: stewart da. Expert Opin Biol Ther. 2014 Aug;14(8):1197-205. doi: 10.1517/14712598.2014.922535. Epub 2014 May 23. Expert Opin Biol Ther. 2014. PMID: 24856933 Review.
Targeting non-Hodgkin lymphoma with blinatumomab.
Sanders S, Stewart DA. Sanders S, et al. Among authors: stewart da. Expert Opin Biol Ther. 2017 Aug;17(8):1013-1017. doi: 10.1080/14712598.2017.1334053. Epub 2017 Jun 1. Expert Opin Biol Ther. 2017. PMID: 28532177 Review.
Novel synthetic drugs for the treatment of non-Hodgkin lymphoma.
Manji F, Puckrin R, Stewart DA. Manji F, et al. Among authors: stewart da. Expert Opin Pharmacother. 2021 Aug;22(11):1417-1427. doi: 10.1080/14656566.2021.1902988. Epub 2021 Mar 25. Expert Opin Pharmacother. 2021. PMID: 33711241 Review.
Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease.
Khanolkar RA, Tripathi G, Dharmani-Khan P, Dabas R, Kinzel M, Kalra A, Puckrin R, Jimenez-Zepeda V, Jamani K, Duggan PR, Chaudhry A, Bryant A, Stewart DA, Khan FM, Storek J. Khanolkar RA, et al. Among authors: stewart da. Cytotherapy. 2022 Dec;24(12):1225-1231. doi: 10.1016/j.jcyt.2022.07.013. Epub 2022 Sep 1. Cytotherapy. 2022. PMID: 36057497
Comparison of the Management and Short-Term Outcomes between Patients with Advanced Cancer and Other End-of-Life Conditions Presenting to Two Canadian Emergency Departments.
Kirkland SW, Yang EH, Clua MG, Kruhlak M, Villa-Roel C, Elwi A, O'Neill B, Duggan S, Brisebois A, Stewart DA, Rowe BH. Kirkland SW, et al. Among authors: stewart da. J Palliat Med. 2022 Jun;25(6):915-924. doi: 10.1089/jpm.2021.0519. Epub 2022 Feb 3. J Palliat Med. 2022. PMID: 35119311
72 results